 | Thayse, K., Brogniet, S., Carlier, S., Kindt, N., & Tassin, A. (13 February 2020). Comparison of Vascular Cell Adhesion Molecule-1 (VCAM-1) expression following stimulation with TNF alpha on human umbilical vein endothelial cells and EA.hy926 cells for atherosclerosis research. Paper presented at 39th Annual Belgian Society of Cardiology Meeting, Bruxelles, Unknown/unspecified. |
| Seminerio, I., Descamps, G., Dupont, S., de Marrez, L., Laigle, J.-A., Lechien, J., Kindt, N., Journe, F., & Saussez, S. (15 February 2019). Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma. Cancers, 11 (227). doi:10.3390/cancers11020227  Peer reviewed |
| Kindt, N., Descamps, G., Lechien, J., Remmelink, M., Colet, J.-M., Wattiez, R., Berchem, G., Journe, F., & Saussez, S. (02 February 2019). Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma. Journal of Clinical Medicine, 1#0 (8). Peer reviewed |
Kindt, N., Journe, F., Ghanem, G., & Saussez, S. (18 December 2017). Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas. International Journal of Molecular Sciences, 18 (12). Peer Reviewed verified by ORBi |
Lechien, J., Nassri, A., Kindt, N., Brown, D., Journe, F., & Saussez, S. (2017). Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review. Head & Neck. Peer Reviewed verified by ORBi |
Kindt, N., Descamps, G., Seminerio, I., Bellier, J., Lechien, J., Mat, Q., Pottier, C., Delvenne, P., Journe, F., & Saussez, S. (22 September 2017). High stromal Foxp3-positive T cell number combined to tumor stage improved prognosis in head and neck squamous cell carcinoma. Poster session presented at Second symposium of the ULB-cancer research center, Bruxelles, Belgium. |
Seminerio, I., Kindt, N., Descamps, G., Bellier, J., Lechien, J., Mat, Q., Pottier, C., Delvenne, P., Journe, F., & Saussez, S. (18 May 2017). Stromal FoxP3-positive T Cell Number Combined to Tumor Stage Improves Prognosis in Head and Neck Squamous Cell Carcinoma. Poster session presented at BIT's 10th Annual World Cancer Congress 2017, Barcelona, Spain. |
Buxant, F., Kindt, N., Noel, J., Laurent, G., & Saussez, S. (16 March 2017). Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy. Breast Cancer - Targets and Therapy, 9, 171-175. Peer reviewed |
Kindt, N., Descamps, G., Seminerio, I., Bellier, J., Lechien, J., Mat, Q., Pottier, C., Delvenne, P., Journe, F., & Saussez, S. (08 March 2017). High stromal Foxp3-positive T cell number combined to tumor stage improved prognosis in head and neck squamous cell carcinoma. Oral Oncology, 67, 183-191. Peer Reviewed verified by ORBi |
Kindt, N., Descamps, G., Seminerio, I., Bellier, J., Lechien, J., Pottier, C., Larsimont, D., Journe, F., Delvenne, P., & Saussez, S. (01 November 2016). Langerhans cell number is a strong and independent prognostic factor for head and neck squamous cell carcinomas. Oral Oncology, 62 (2016), 1-10. Peer Reviewed verified by ORBi |
| Richard, V., Conotte, R., Kindt, N., Saussez, S., & Colet, J.-M. (07 October 2016). Macrophage migration inhibitory factor (MIF) involvement in breast cancer cell metabolism: A 1H-NMR spectroscopy evaluation. Poster session presented at ESMO 2016 Congress From disease treatment to patient care, Copenhagen, Denmark. |
Kindt, N., Journe, F., Laurent, G., & Saussez, S. (02 August 2016). Involvement of macrohage migration inhibitory factor in cancer and novel therapeutic targets (Review). Oncology Letters, 12, 2247-2253. Peer Reviewed verified by ORBi |
Descamps, G., Karaca, Y., Lechien, J., Kindt, N., Decaestecker, C., Remmelink, M., Larsimont, D., Andry, G., Hassid, S., Rodriguez, A., Khalife, M., Journe, F., & Saussez, S. (01 July 2016). Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients. Journal of Cancer Research and Clinical Oncology, 152 (10), 2185-2196. Peer Reviewed verified by ORBi |
Descamps, G., Karaca, Y., Lechien, J., Kindt, N., Decaestecker, C., Remmelink, M., Andry, G., Rodriguez, A., Khalife, M., Journe, F., & Saussez, S. (30 January 2016). The classical risk factors predict recurrence and survival after concomitant chemoradiotherapy in advanced head and neck cancer patients unlike the HPV status. Poster session presented at BACR Annual Meeting, ULB Erasme, Belgium. |
Kindt, N., Bol, V., Schneider, K., Grégoire, V., & Saussez, S. (22 September 2015). Relationship between Macrophage migration Inhibitory Factor and HPV infection in head and neck squamous cell carcinoma. Poster session presented at 2nd International Symposium of the cancer research center of Lyon, Lyon, France. |
 | Kindt, N., Lechien, J., Nonclercq, D., Laurent, G., & Saussez, S. (11 June 2014). Involvement of CD74 in head and neck squamous cell carcinomas. Journal of Cancer Research and Clinical Oncology, 140 (6), 937-947. Peer Reviewed verified by ORBi |
Lechien, J., Kindt, N., Costa, P., Preillon, J., Chantrain, G., Laurent, G., & Saussez, S. (01 April 2013). MIF in Head and Neck cancer: a new therapeutic target ? : Le MIF dans les cancers des voies aéro-digestives supérieures : une nouvelle thérapie ciblée ? Revue de Laryngologie - Otologie - Rhinologie, 134 (2), 67-74. Peer Reviewed verified by ORBi |
Kindt, N., Preillon, J., Laurent, G., Gabius, H.-J., Decaestecker, C., Johnson, B., Chantrain, G., & Saussez, S. (14 February 2013). Involvement of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma. Poster session presented at 1st Symposium of Cancer Research Center of Lyon, Lyon, France. |
| Richard, V., Conotte, R., Kindt, N., Faverly, D., Laurent, G., Colet, J.-M., Noël, J. C., & Saussez, S. (29 January 2013). INTEGRATING PROTEOMICS AND METABONOMICS FOR A BETTER UNDERSTANDING OF HUMAN BREAST CANCER BIOLOGY. Poster session presented at 1ère journée des doctorants en Sciences Biomédicales et Pharmaceutiques, Mons, Belgium. |
| Kindt, N., Lechien, J., Journé, F., Ghanem, G., Duvillier, H., Laurent, G., & Saussez, S. (29 January 2013). Involvement of CD74 in head and neck squamous cell carcinoma. Paper presented at 1ère journée des doctorants en Sciences Biomédicales et Pharmaceutiques, Mons, Belgium. |
Kindt, N., Preillon, J., Kaltner, H., Gabius, H.-J., Chevalier, D., Rodriguez, A., Johnson, B., Megalizzi, V., Decaestecker, C., Laurent, G., & Saussez, S. (25 January 2013). Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies. Journal of Cancer Research and Clinical Oncology, 139 (5), 727-737. Peer Reviewed verified by ORBi |
| Kindt, N., Laurent, G., Nonclercq, D., Journé, F., Ghanem, G., Duvillier, H., Gabius, H.-J., Lechien, J., & Saussez, S. (12 January 2013). Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells. International Journal of Oncology, 43 (1), 185-193. Peer Reviewed verified by ORBi |
Kindt, N., Lechien, J., Decaestecker, C., Rodriguez, A., Chantrain, G., Remmelink, M., Laurent, G., Gabius, H.-J., & Saussez, S. (12 October 2012). Expression of Macrophage Migration-Inhibitory Factor is Correlated with Progression in Oral Cavity Carcinomas. Anticancer Research, 32 (10), 4499-4506. Peer Reviewed verified by ORBi |
| Cludts, S., Decaestecker, C., Johnson, B., Lechien, J., Leroy, X., Kindt, N., Kaltner, H., André, S., Gabius, H.-J., & Saussez, S. (02 June 2010). Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma. Anticancer Research, 30, 3313-3320. Peer Reviewed verified by ORBi |